Bayer Aktiengesellschaft Stock
Bayer Aktiengesellschaft
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Germany
- CEO
- Bill Anderson
- Employees
- 87,830
- Market cap
- €43.7 B
- IPO
- 16/12/1996
Bayer Aktiengesellschaft is a life science company headquartered in Leverkusen, Germany. Founded in 1863, the company is listed on the XETRA exchange. The business operates through three segments: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals segment provides prescription products primarily…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Bayer Aktiengesellschaft stock: price history
1D
+0.1%
1W
+1.6%
1M
-9.2%
6M
+8.2%
YTD
+20.1%
1Y
+64.1%
2Y
+68.2%
5Y
-7.1%
10Y
-50.2%
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~45% stronger price swings than usual
Bayer Aktiengesellschaft stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Bayer Aktiengesellschaft
Analyst assessment of Bayer Aktiengesellschaft
0
STRONG BUY
1
BUY
2
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Hold
As of: 30/09/2020
Bayer Aktiengesellschaft stock metrics
P/E
-25.26
P/B
1.48
EV/EBITDA
15.33
RETURN ON EQUITY
0.7%
NET MARGIN
2.0%
DEBT/EQUITY
1.3
DIVIDEND YIELD
0.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
100.0%
FLOAT SHARES
982,420,000
AVG. DAILY VOLUME (30D)
2,284,856
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Bayer Aktiengesellschaft stock
What does Bayer Aktiengesellschaft do?
Bayer Aktiengesellschaft is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in Germany.
The CEO is Bill Anderson, the company employs around 87,830 people.
The IPO was on 16/12/1996; the stock trades on XETRA under the ticker BAYN.DE.
What do analysts say about Bayer Aktiengesellschaft stock?
3 analysts rate the stock, the consensus is Hold (as of 30/09/2020).
This is an external assessment, not a statement by Market Jury.
When does Bayer Aktiengesellschaft report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 45% stronger than usual.
Does Bayer Aktiengesellschaft pay a dividend?
Yes. The last dividend was €0.11 per share, ex-date 27/04/2026, paid on 29/04/2026.
The dividend yield is 0.2% (as of 30/06/2026).
Which stocks are comparable to Bayer Aktiengesellschaft?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen, Gilead Sciences and Pfizer.
How can I get Bayer Aktiengesellschaft stock analyzed?
Clicking "Analyze stock" lets five strategies assess Bayer Aktiengesellschaft against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.